Full- or Half-Cycle Treatment of Severe Premenstrual Syndrome With a Serotonergic Antidepressant
The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
Evidence that serotonergic antidepressants are effective for treating premenstrual syndrome (PMS) raises the question of whether dosing only in the symptomatic premenstrual phase is effective for this disorder. This preliminary randomized, double-blind study compared the responses to half-cycle or full-cycle dosing of sertraline in 31 patients who completed a preceding double-blind, short-term treatment trial. The subjects fulfilled criteria for severe PMS when they entered the preceding controlled trial. At the end of the short-term treatment trial, the double-blind was not broken; both improved and unimproved subjects were randomized in a double-blind fashion to receive either full-cycle or half-cycle sertraline in the 3-month extension study. Results showed that the total premenstrual scores from the Penn Daily Symptom Report (DSR) were lower in the half-cycle dosing group in each of the 3 treatment months but did not differ with statistical significance from the full-cycle dosing group. Further analysis of the 17 DSR items showed that mood swings, nervous tension, feeling out of control, and confusion were significantly lower (p < 0.05) at endpoint in the half-cycle dosing group. Overall, subjects who improved in prior treatment remained improved; approximately half the subjects who were unimproved at entry into the extension study improved, regardless of the dosing regimen. The results add support to other preliminary reports of efficacy of serotonergic antidepressants administered premenstrually and indicate the clinical importance of determining an optimal dose/benefit ratio of serotonergic antidepressants for PMS patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Serotonin Levels and Platelet Uptake during Premenstrual Tension
Taylor, D. L., Mathew, R. J., Ho, B. T., & Weinman, M. L. (2008) · Neuropsychobiology · doi:10.1159/000118103 · Cited by 131
Cited by
The premenstrual symptoms screening tool (PSST) for clinicians
Steiner, M., Macdougall, M., & Brown, E. (2003) · Archives of Women's Mental Health · doi:10.1007/s00737-003-0018-4 · Cited by 641
“Prospective daily charting has been used primarily in PMS=PMDD randomized clinical trials (Sundblad et al., 1993; Steiner et al., 1995; Yonkers et al., 1997; Wikander et al., 1998; Freeman et al., 1999; Pearlstein et al., 2000; Dimmock et al., 2000; Halbreich et al., 2002; Cohen et al., 2002).”
MethodSelective serotonin reuptake inhibitors for premenstrual syndrome
Marjoribanks, J., Brown, J., O'Brien, P. M. S., & Wyatt, K. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001396.pub3 · Cited by 413
Efficacy of selective serotonin-reuptake inhibitors in premenstrual syndrome: A systematic review
Dimmock, P. W., Wyatt, K. M., Jones, P. W., & O'Brien, P. S. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02754-9 · Cited by 368
Reed, S. C., Levin, F. R., & Evans, S. M. (2008) · Hormones and Behavior · doi:10.1016/j.yhbeh.2008.02.018 · Cited by 170
“For example, sertraline did not alter food cravings or appetite compared toplaceboordesipramine (Freemanet al.,1999a) orwhen fulland half-cycle treatments of sertraline were compared (Freeman et al., 1999b).”
Pearlstein, T. (2002) · Drugs · doi:10.2165/00003495-200262130-00004 · Cited by 53
“, 1999[46] DB, parallel; 3 cycles full cycle sertraline 50-150”
BackgroundMethod
Metadata
- Authors
- Freeman, E. W., Rickels, K., Arredondo, F., Kao, L.-C., Pollack, S. E., & Sondheimer, S. J.
- Venue
- Journal of Clinical Psychopharmacology
- Published
- 1999-02
- Volume
- 19
- Issue
- 1
- Pages
- 3-8
- ISSN
- 0271-0749 (ISSN-L)
- OpenAlex
- W2074931679
- Cited by
- 75
- References
- 1
- FWCI
- 10.83
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Full- or Half-Cycle Treatment of Severe Premenstrual Syndrome With a Serotonergic Antidepressant. https://app.cochat.ai/papers/10.1097/00004714-199902000-00002
- The paper
- Freeman, E. W., Rickels, K., Arredondo, F., Kao, L.-C., Pollack, S. E., & Sondheimer, S. J. (1999). Full- or Half-Cycle Treatment of Severe Premenstrual Syndrome With a Serotonergic Antidepressant. Journal of Clinical Psychopharmacology. https://doi.org/10.1097/00004714-199902000-00002
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.